Policy & access
The EveryLife Foundation has submitted comments to the FDA on the Reauthorization of Medical Device User Fee Agreements (MDUFA) for fiscal years 2028 and beyond. This initiative could impact the regulatory landscape for medical devices affecting rare diseases.
The EveryLife Foundation for Rare Diseases has submitted written comment to the FDA regarding the initiation of the Reauthorization of Medical Device User Fee Agreements (MDUFA) for fiscal years 2028 […] The post EveryLife Foundation submits written comment to the FDA on the Reauthorization of Medical Device User Fee Agreements (MDUFA) appeared first on EveryLife Foundation for Rare Diseases.
Original title: “EveryLife Foundation submits written comment to the FDA on the Reauthorization of Medical Device User Fee Agreements (MDUFA)”